Author

Luiza Barseghyan

Institution: Loma Linda University

Observed institution: Loma Linda University

OpenAlex ID: A5116692853

Mutational Landmarks in Anaplastic Thyroid Cancer: A Perspective of a New Treatment Strategy

2025 · Janice Pakkianathan, Celena R. Yamauchi, et al. · Journal of Clinical Medicine · 13

Unraveling Racial Disparities in Papillary Thyroid Cancer: A Comparative Bulk RNA-Sequencing Gene Expression Analysis

2025 · Luiza Barseghyan, Samuel Chan, et al. · Current Oncology · 5

The Sex Paradox in Papillary Thyroid Carcinoma: Higher Incidence in Women, Poorer Outcomes in Men, and an Emerging Non-Coding RNA Layer

2026 · Luiza Barseghyan, Olabisi Bamidele, et al. · Genes

Abstract B041: Hypoxia up-regulated protein 1 and its related genes as potential prognostic markers in papillary thyroid cancer

2026 · Olabisi T. Bamidele, James Kuo, et al. · Cancer Epidemiology Biomarkers & Prevention

Semaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms

2026 · Luiza Barseghyan, Iqbal Munir, et al. · Journal of Clinical Medicine

Works count: 5

Citation count: 18

H-index: 2

I10-index: 1